文献速递慢性肾脏病

单细胞分辨率解析ZSF1大鼠糖尿病肾病中依那普利的作用

Single-Cell Resolution Drug Effects of Renin-Angiotensin-Aldosterone Blockade in ZSF1 Rat Diabetic Kidney Disease.
PubMed 文献 · J Am Soc Nephrol · 2026-01-07

本研究利用Zucker自发性高血压肥胖大鼠的单细胞转录组学,解析依那普利在糖尿病肾病中的靶细胞和驱动分子。研究发现组织肾素-血管紧张素-醛固酮系统效应分子组织蛋白酶D调控依那普利在远端肾单位损伤状态下的效应,并揭示表达髓系细胞触发受体2的驻留巨噬细胞是远端肾单位信号的主要接收者。依那普利相关基因特征可对人肾脏样本按纤维化和肾功能结局进行分层。

要点

  • 组织蛋白酶D调控依那普利在糖尿病肾病远端肾单位损伤中的作用。
  • 依那普利减少与远端肾单位细胞互作的促炎TREM2+巨噬细胞。
  • 依那普利相关基因特征可分层人类肾脏的纤维化和功能结局。

核心结论

  • 组织蛋白酶D是依那普利效应的重要调节因子,涉及远端肾单位与TREM2+驻留巨噬细胞的交互。
  • 依那普利相关基因特征可依据肾功能和纤维化等疾病相关结局指标对人肾脏样本进行分层。

研究设计与样本

  • 在Zucker自发性高血压肥胖大鼠中采用单细胞转录组学,以阐明依那普利的潜在靶细胞和驱动分子。

主要发现

  • 长期依那普利治疗背景下,鉴定出远端肾单位的损伤细胞状态。
  • 组织蛋白酶D作为组织肾素-血管紧张素-醛固酮系统效应分子,是依那普利效应的重要调节因子。
  • 表达髓系细胞触发受体2的驻留巨噬细胞是远端肾单位来源信号的主要接收者。
  • 依那普利相关基因特征可依据肾功能和纤维化对人肾脏样本进行分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Cathepsin D regulated enalapril effects in distal nephron injury states of diabetic kidney disease. Enalapril reduced proinflammatory triggering receptor expressed on myeloid cells 2+ macrophages interacting with distal nephron cells. Enalapril-associated gene signatures stratified human kidneys by fibrosis and function outcomes. BACKGROUND: Diabetic kidney disease is the leading cause of kidney failure worldwide. Renin-angiotensin-aldosterone system inhibitors, such as enalapril, have been used for decades as antiproteinuric, antihypertensive, and kidney-protective agents. Still, the exact cell type of action and the molecular mechanism of drug action are elusive. Previous work has primarily emphasized injury patterns in the proximal nephron, leaving potential contributions of other nephron segments insufficiently characterized. METHODS: Here, we leveraged state-of-the-art single-cell transcriptomics in the Zucker spontaneously hypertensive fatty obese rat to elucidate potential target cells and driver molecules exerting enalapril drug effects. RESULTS: We identified injured cell states of the distal nephron in the context of prolonged enalapril treatment. We showed cathepsin D, a tissue renin-angiotensin-aldosterone system effector, as an important regulator of enalapril effects and revealed triggering receptor expressed on myeloid cells 2+ residential macrophages as top receivers of distal nephron-derived signals. Finally, we showed that enalapril-associated gene signatures allow stratification of human kidney samples by disease-relevant outcome measures such as kidney function and fibrosis. CONCLUSIONS: We reported cathepsin D as an important regulator of enalapril effects, involving cross-talk between the distal nephron and triggering receptor expressed on myeloid cells 2+ residential macrophages. We also demonstrated that enalapril-associated gene signatures allow stratification of human kidney samples by disease-relevant outcome measures.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Balzer MS, Zhou J, Abedini A, et al. Single-Cell Resolution Drug Effects of Renin-Angiotensin-Aldosterone Blockade in ZSF1 Rat Diabetic Kidney Disease. J Am Soc Nephrol. 2026. PMID: 41563360. doi:10.1681/ASN.0000000995

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。